Cite
HARVARD Citation
Mailankody, S. et al. (2022). Ixazomib and dexamethasone in high risk smoldering multiple myeloma: a clinical and correlative pilot study. Leukemia & lymphoma. 63 (11), pp. 2760-2761. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mailankody, S. et al. (2022). Ixazomib and dexamethasone in high risk smoldering multiple myeloma: a clinical and correlative pilot study. Leukemia & lymphoma. 63 (11), pp. 2760-2761. [Online].